about
Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosisAn in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection.miRNA signatures in sera of patients with active pulmonary tuberculosisMycobacterium lentiflavum infection in immunocompetent patientFirst evaluation of QuantiFERON-TB Gold Plus performance in contact screening.Pregnancy in patients with tuberculosis: a TBNET cross-sectional survey.Active Tuberculosis Case Finding Interventions Among Immigrants, Refugees and Asylum Seekers in Italy.Lessons learnt from TB screening in closed immigration centres in ItalyInfluence of Hospitalization upon Diagnosis on the Risk of Tuberculosis Clustering.Characterizing Non-Tuberculous Mycobacteria Infection in Bronchiectasis.Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy.Challenges and perspectives in the diagnosis of extrapulmonary tuberculosis.Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.Differential diagnosis of cervical mycobacterial lymphadenitis in children.Comparison between spoligotyping and IS6110 restriction fragment length polymorphisms in molecular genotyping analysis of Mycobacterium tuberculosis strains.Mycobacterium tuberculosis Beijing family: analysis of the epidemiological and clinical factors associated with an emerging lineage in the urban area of Milan.Genotyping analyses of tuberculosis transmission among immigrant residents in Italy.Tuberculosis control in big cities and urban risk groups in the European Union: a consensus statement.Tuberculosis outbreak in a primary school, Milan, Italy.Circulating, Mycobacterium tuberculosis-specific lymphocytes from PPD skin test-negative patients with tuberculosis do not secrete interferon-gamma (IFN-gamma) and lack the cutaneous lymphocyte antigen skin-selective homing receptor.Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study.Exogenous reinfection of tuberculosis in a low-burden area.Tuberculosis-related stigma leading to an incomplete contact investigation in a low-incidence country.The spread of drug-resistant tuberculosis in children: an Italian case series.Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients.Long-term moxifloxacin in complicated tuberculosis patients with adverse reactions or resistance to first line drugs.Incidence of venous thromboembolism in tuberculosis patients.Pulmonary disease by non-tuberculous mycobacteria - clinical management, unmet needs and future perspectives.First independent evaluation of QuantiFERON-TB Plus performance.Managing an extensively drug-resistant tuberculosis outbreak: the public health face of the medal.The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection.The Italian registry of pulmonary non-tuberculous mycobacteria - IRENE: the study protocolClinical and operational value of the extensively drug-resistant tuberculosis definitionRipped from the headlines: how can we harness communications to control TB?Microbiological confirmation of tuberculosis cases at diagnosis and at the end of treatment in ItalyEffect of therapy on Quantiferon-Plus response in patients with active and latent tuberculosis infectionUse of a T-cell interferon- release assay for the diagnosis of tuberculous pleurisyImplementing TB control in a rural, resource-limited setting: the stop-TB Italia project in Senegal
P50
Q33972593-49478104-8C5A-4039-92F8-C8583876C9CAQ34719407-4442E86A-D6A7-4B0A-BEB4-A3D88F7AE1A3Q35053468-9C1D047A-D938-4844-A662-1318227A0A37Q35804276-59E755B5-15AB-464F-B4B4-53940D75CE68Q36070684-557A4BF5-CCF2-4076-AF78-15A52FBBCEEEQ36160780-E5809A39-BE26-4C17-B1B5-ABE4F29FBAA5Q37054030-6DF2F79F-AD69-41D7-AD60-BA3CEA50CEA6Q37291587-A3AE1F75-5894-4C4F-809C-9165FE2D0250Q37401778-C694E909-48AD-4290-B259-1938AE7068E0Q37465667-2C49EE84-9CA3-4D55-8248-E563E619BBBBQ37669577-4C17A2F9-F205-4DD8-B59A-5699EB8E7557Q38203355-13E896B6-3BD2-4716-8A3D-4FCD8F9FE3D6Q38915347-210D950E-34D1-4307-BF44-5CFDB371977EQ38933464-158E9A3E-CA2E-4A24-B10F-FE29D7B87CEFQ39029343-8171C78C-7358-4681-BFAE-B9DD8AC1C3D1Q39217256-F8FCEC85-9383-4A0C-879D-A8D895E021CAQ39904077-ED819F1E-5375-43AD-B38D-14FF1BA2DAACQ40177348-F2949FEB-7A97-404C-8DB8-617C2C12AEB2Q40511403-00478B2C-8782-46F0-A427-88A1BDC1B1AEQ40910744-E00B8CEE-BE89-4C50-A7CA-ACE67BD02456Q41436229-CEE632EA-606F-42D9-9C2A-0119E895F724Q41441140-632C0162-0592-4229-8DF9-81634B6CBB33Q41534261-93BDBE92-435B-40E5-8F5D-8E94F85E61E6Q42230437-5B46C101-92AE-415B-B0F1-BE0242269F23Q42715629-3F49334C-A2F8-4324-90DB-5B0850AA3C13Q44312351-51B0BD6C-6605-4131-A274-FBE534E4A15CQ44581271-1C542E9E-8601-4DE5-9E8E-B8D54DF94344Q46937150-D1311CC3-6728-4AFB-87C5-B28A37FB7F3EQ47648876-A4D5DCE6-9BE4-41A0-B8EC-455A46967F79Q47756838-E6AB95E2-8F06-4E1C-BBAA-FF367E12B7BAQ51547660-E86020CC-34F0-4FA0-99E7-BBF453023AD0Q51839030-C01A7486-E645-4576-B030-29FF4C9F881FQ53843588-911B9687-13DD-4C4A-A2AA-DB17873275AAQ56523700-2A03D613-326B-46F7-8A7C-8773D00CE33CQ56833417-24442E2A-D93D-4FE9-8A20-573A8406233AQ56833425-9F2F0B77-0819-4F22-9BB8-B7E48B11BAF6Q56838319-23A9D974-70DC-4462-88DA-3316E188EA3CQ57799796-871C4636-C719-4CA7-9241-27C685BC2E91Q58321577-7E3061E5-BA61-4884-BDA4-7598F3779AD9Q59137020-5EA0B707-2469-4F3F-8890-FBEB26FF14F3
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Luigi Codecasa
@ast
Luigi Codecasa
@en
Luigi Codecasa
@es
Luigi Codecasa
@nl
type
label
Luigi Codecasa
@ast
Luigi Codecasa
@en
Luigi Codecasa
@es
Luigi Codecasa
@nl
prefLabel
Luigi Codecasa
@ast
Luigi Codecasa
@en
Luigi Codecasa
@es
Luigi Codecasa
@nl
P106
P21
P31
P496
0000-0001-6825-2050